296 related articles for article (PubMed ID: 2550644)
1. A comparison of single doses of lisinopril and enalapril in hypertension.
Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
Gosse P; Dallocchio M; Gourgon R
J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
[TBL] [Abstract][Full Text] [Related]
4. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
Espinel CH; Williams JL; Coughlin SS
Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
[TBL] [Abstract][Full Text] [Related]
5. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
Witchitz S; Serradimigni A
J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of lisinopril in elderly patients with mild to moderate hypertension.
Marlier R; Vandepapelière P; De Vriese G
J Hum Hypertens; 1989 Jun; 3 Suppl 1():163-7. PubMed ID: 2550639
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
Herpin D; Conte D
J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hypertension with the ACE inhibitor lisinopril. A multicenter study of patients with mild to moderate hypertension in general practice].
Landmark K; Tellnes G; Fagerthun HE; Larsen S
Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3176-9. PubMed ID: 1658975
[TBL] [Abstract][Full Text] [Related]
9. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
Motero Carrasco J
Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
[TBL] [Abstract][Full Text] [Related]
10. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension.
Johnston GD; Banks DC; Davies S; Duffin D; Garnham JC; Nicholls DP; Raj MV; Mansy S; Sloan P; Strouthidis TM
J Hum Hypertens; 1991 Oct; 5(5):405-10. PubMed ID: 1663163
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
[TBL] [Abstract][Full Text] [Related]
12. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
[TBL] [Abstract][Full Text] [Related]
13. A clinical pharmacological study of nifedipine and lisinopril alone and in combination.
Lees KR; Meredith PA; Reid JL
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S105-7. PubMed ID: 2455105
[TBL] [Abstract][Full Text] [Related]
14. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
Mörlin C; Baglivo H; Boeijinga JK; Breckenridge AM; Clement D; Johnston GD; Klein W; Kramer R; Luccioni R; Meurer KA
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S49-52. PubMed ID: 2442552
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
Jackson B; Cubela R; Johnston CI
J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
Wallis EJ; Ramsay LE; Hettiarachchi J
Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
[TBL] [Abstract][Full Text] [Related]
17. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter clinical study of the antihypertensive activity of lisinopril].
Cinotti GA; Bossini A; Cagli V; Corea L; Di Veroli C; Morabito S; Pierucci A; Porcellati C; Savino K; Timio M
Minerva Med; 1989 Jan; 80(1):53-63. PubMed ID: 2536907
[TBL] [Abstract][Full Text] [Related]
19. Lisinopril and enalapril in hypertension: a comparative study using ambulatory monitoring.
Conway J; Coats AJ; Bird R
J Hum Hypertens; 1990 Jun; 4(3):235-9. PubMed ID: 2163450
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril in essential hypertension: a six month comparative study with nifedipine.
Richardson PJ; Meany B; Breckenridge AM; Grimmer SF; Johnston GD; Kondowe G
J Hum Hypertens; 1987 Dec; 1(3):175-9. PubMed ID: 2852252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
